Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Update of PNU-145156E phase I trial presented at ASCO meeting

May 27, 1999

Techniclone initiates phase I/II trial of TNT for solid tumors, reports phase I brain cancer results

May 27, 1999

MGI Pharma expands ovarian cancer trial with MGI-114

May 27, 1999

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

May 26, 1999

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

May 26, 1999

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

May 26, 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

May 26, 1999

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

May 25, 1999

SkyePharma announces U.S. launch of DepoCyt

May 25, 1999

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...